Dept. of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85, Uppsala, Sweden.
J Immunol Methods. 2010 Feb 28;353(1-2):71-7. doi: 10.1016/j.jim.2010.01.005. Epub 2010 Jan 18.
Human phospholipase B-precursor (PLB-P) is a newly identified and purified protein from human neutrophils. The precise function of PLB-P in vivo is not yet known. Its existence in neutrophils and the enzymatic activity against phospholipids imply a role in the defence against invading microorganisms and in the generation of lipid mediators of inflammation. We describe here the generation of specific antibodies against PLB-P, the tissue localizations of PLB-P and the establishment of an accurate, specific, and reproducible radioimmunoassay (RIA). A survey of normal and malignant tissues showed strong immunostaining of PLB-P in neuronal and myeloid cells and in adrenal glands. Elevated levels were found in sera of patients with influenza A infection i.e. >1 microg/L and in gut fluids of patients with inflammatory bowel disease i.e. >20 microg/L. The levels correlated to markers of neutrophil activation, suggesting a neutrophil origin of PLB-P in these conditions. The antibodies and the assay will be useful in the future basic and clinical investigations of PLB-P.
人源磷酯酶 B 前体(PLB-P)是从人中性粒细胞中鉴定和纯化的一种新蛋白。PLB-P 在体内的确切功能尚不清楚。它在中性粒细胞中的存在及其对磷脂的酶活性提示其在防御入侵微生物和产生炎症脂质介质方面的作用。本文描述了针对 PLB-P 的特异性抗体的产生、PLB-P 的组织定位以及准确、特异和可重现的放射免疫分析(RIA)的建立。对正常和恶性组织的调查显示,PLB-P 在神经元和髓样细胞以及肾上腺中具有强烈的免疫染色。在甲型流感感染患者的血清中发现了升高的水平,即 >1 μg/L,在炎症性肠病患者的肠道液中也发现了升高的水平,即 >20 μg/L。这些水平与中性粒细胞活化标志物相关,提示在这些情况下 PLB-P 来源于中性粒细胞。这些抗体和检测方法将有助于未来对 PLB-P 的基础和临床研究。